Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Strabag SE, Porr, UBM Development, Marinomed Biotech AG (29/11/2018)

29.11.2018

Strabag: Construction company Strabag SE has adjusted upwards its outlook for the full year on the occasion of the publication of the nine-month figures for 2018. The company generated an output volume of Euro 11,645.81 mn in the first nine months of the 2018 financial year. The order backlog increased by 13 % over the level of 30 September 2017 to Euro 18,161.02 mn. The net income came at Euro 187.76 mn (+116 %). “Dynamic growth in our by far largest market of Germany; continued good demand in the countries of Central and Eastern Europe; favourable construction weather all around; no more earnings burdens from our international business – this has been the year to date. With developments such as these, we are adjusting our outlook for the 2018 full year: We now expect the output volume to clearly exceed € 15.0 billion and the operating EBIT margin to attain at least last year’s level of 3.3 %. These forecasts lead us to anticipate another record year,” says Thomas Birtel, CEO of Strabag SE.
Strabag: weekly performance: 2.79%

Porr: Austrian based construction group Porr AG AG is continuing this year’s trend with a good third quarter. New records were once again set in both production output and the order backlog. As expected, production output rose in the first nine months by 21.3% to Euro 4,055 mn. In a challenging environment, EBT totalled Euro 31.2 mn, a plus of 9.9%. The order backlog of Euro 6,837 mn is again at a record level, representing a growth of 17.7%.“Today Porr is on a solid footing. Despite the challenging market environment, we have been able to stand our ground”, said Karl-Heinz Strauss, CEO of Porr. He ads: “The high cushion of orders gives us momentum and we remain right on track with our capacity fully utilised. We continue to see growing markets; for the full-year we expect production output to increase to at least Euro 5.3 bn. Despite market challenges we are looking at a good year”.
Porr: weekly performance: -8.47%

UBM: UBM Development, leading hotel developer in Europe, remains on record course after nine months: Earnings per share rose substantially by 30% year-on-year to Euro 3.66 in the first three quarters. The other fundamental parameters like Total Output (+26.5% to Euro 670 mn) and EBT (+15.8% to Euro 35.4 mn) also suggest that the full 2018 financial year will top the previous record results. The equity ratio equalled 37.3% and net debt amounted to Euro 329.7 mn at the end of the third quarter of 2018. “This very low debt level gives us the flexibility for new projects which will secure our future profitability today“, commented Thomas G. Winkler, CEO of UBM Development. The company aims to invest Euro 150-200m in the acquisition of new projects during the fourth quarter.
UBM: weekly performance: 2.21%

Marinomed Biotech AG:  Marinomed  suspends the offer period of the current IPO. While firm investor participation to buy new shares was obtained, the current adverse market conditions with high volatility did not allow to fully achieve the targeted offer volume, the company stated. Marinomed plans to resume the offer period presumably at the beginning of 2019.

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (29/11/2018)


Partners









latest 21st Austria

21st Austria weekly - Strabag SE, Porr, UBM Development, Marinomed Biotech AG (29/11/2018)


29.11.2018



Strabag: Construction company Strabag SE has adjusted upwards its outlook for the full year on the occasion of the publication of the nine-month figures for 2018. The company generated an output volume of Euro 11,645.81 mn in the first nine months of the 2018 financial year. The order backlog increased by 13 % over the level of 30 September 2017 to Euro 18,161.02 mn. The net income came at Euro 187.76 mn (+116 %). “Dynamic growth in our by far largest market of Germany; continued good demand in the countries of Central and Eastern Europe; favourable construction weather all around; no more earnings burdens from our international business – this has been the year to date. With developments such as these, we are adjusting our outlook for the 2018 full year: We now expect the output volume to clearly exceed € 15.0 billion and the operating EBIT margin to attain at least last year’s level of 3.3 %. These forecasts lead us to anticipate another record year,” says Thomas Birtel, CEO of Strabag SE.
Strabag: weekly performance: 2.79%

Porr: Austrian based construction group Porr AG AG is continuing this year’s trend with a good third quarter. New records were once again set in both production output and the order backlog. As expected, production output rose in the first nine months by 21.3% to Euro 4,055 mn. In a challenging environment, EBT totalled Euro 31.2 mn, a plus of 9.9%. The order backlog of Euro 6,837 mn is again at a record level, representing a growth of 17.7%.“Today Porr is on a solid footing. Despite the challenging market environment, we have been able to stand our ground”, said Karl-Heinz Strauss, CEO of Porr. He ads: “The high cushion of orders gives us momentum and we remain right on track with our capacity fully utilised. We continue to see growing markets; for the full-year we expect production output to increase to at least Euro 5.3 bn. Despite market challenges we are looking at a good year”.
Porr: weekly performance: -8.47%

UBM: UBM Development, leading hotel developer in Europe, remains on record course after nine months: Earnings per share rose substantially by 30% year-on-year to Euro 3.66 in the first three quarters. The other fundamental parameters like Total Output (+26.5% to Euro 670 mn) and EBT (+15.8% to Euro 35.4 mn) also suggest that the full 2018 financial year will top the previous record results. The equity ratio equalled 37.3% and net debt amounted to Euro 329.7 mn at the end of the third quarter of 2018. “This very low debt level gives us the flexibility for new projects which will secure our future profitability today“, commented Thomas G. Winkler, CEO of UBM Development. The company aims to invest Euro 150-200m in the acquisition of new projects during the fourth quarter.
UBM: weekly performance: 2.21%

Marinomed Biotech AG:  Marinomed  suspends the offer period of the current IPO. While firm investor participation to buy new shares was obtained, the current adverse market conditions with high volatility did not allow to fully achieve the targeted offer volume, the company stated. Marinomed plans to resume the offer period presumably at the beginning of 2019.

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (29/11/2018)




 

Bildnachweis

Aktien auf dem Radar:Zumtobel, CA Immo, Erste Group, Warimpex, Addiko Bank, UBM, Cleen Energy, Polytec Group, VIG, ATX, ATX Prime, ATX TR, Wienerberger, FACC, Marinomed Biotech, Frequentis, voestalpine, OMV, AMS, Lenzing, RBI, Verbund, Wolford, Rosenbauer, RHI Magnesita, Agrana, Oberbank AG Stamm, EVN, Österreichische Post.


Random Partner

Verbund
Verbund ist Österreichs führendes Stromunternehmen und einer der größten Stromerzeuger aus Wasserkraft in Europa. Mit Tochterunternehmen und Partnern ist Verbund von der Stromerzeugung über den Transport bis zum internationalen Handel und Vertrieb aktiv. Seit 1988 ist Verbund an der Börse.

>> Besuchen Sie 61 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten